ubenimex has been researched along with Acute Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurita, S; Massaoka, T; Ogawa, N; Ota, K; Uzuka, Y; Yamada, K | 1 |
| Asou, N; Emi, N; Hiraoka, A; Jinnai, I; Kageyama, S; Kanamaru, A; Kobayashi, T; Kuriyama, K; Matsuoka, A; Minami, S; Minato, K; Miyawaki, S; Murakami, H; Naoe, T; Oh, H; Ohmoto, E; Ohno, R; Saito, K; Sakamaki, H; Takahashi, I; Tanimoto, M; Tomonaga, M; Tsubaki, K; Yamada, O; Yoshida, M | 1 |
| Horiuchi, K; Miyamoto, T | 1 |
| Fukutani, H; Kimura, I; Miura, Y; Mizoguchi, H; Naoe, T; Ohno, R; Ohshima, T; Omine, M; Saito, H; Tomonaga, M | 1 |
| Ishikawa, T; Nagai, K; Nakayama, S; Yabe, H | 1 |
| Kurita, S; Masaoka, T; Ogawa, N; Ota, K; Uzuka, Y; Yamada, K | 2 |
5 trial(s) available for ubenimex and Acute Disease
| Article | Year |
|---|---|
[Immunotherapy with bestatin for acute non-lymphocytic leukemia (ANLL) in adults].
Topics: Acute Disease; Adjuvants, Immunologic; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Female; Humans; Leucine; Leukemia; Male; Middle Aged | 1984 |
Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leucine; Leukemia, Myeloid; Logistic Models; Male; Mercaptopurine; Middle Aged; Multivariate Analysis; Prednisolone; Prospective Studies; Remission Induction; Survival Rate; Treatment Outcome | 1996 |
Treatment of myelodysplastic syndromes with orally administered N-(2S, 3R)-3-amino-2-hydroxy-4-phenylbutyryl-L-leucine (ubenimex).
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aminopeptidases; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Child; Female; Humans; Leucine; Leukemia; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Prospective Studies | 1991 |
Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults.
Topics: Acute Disease; Adjuvants, Immunologic; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Humans; Leucine; Leukemia; Leukemia, Myeloid; Male; Middle Aged; Random Allocation | 1986 |
[Results of follow-up studies on prognosis after immunotherapy with bestatin in acute nonlymphocytic leukemia].
Topics: Aclarubicin; Acute Disease; Adjuvants, Immunologic; Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Follow-Up Studies; Humans; Leucine; Leukemia; Mercaptopurine; Middle Aged; Naphthacenes; Prednisolone; Prognosis; Random Allocation | 1986 |
2 other study(ies) available for ubenimex and Acute Disease
| Article | Year |
|---|---|
Radioreductive effect of bestatin (Ubenimex) in BALB/c mice.
Topics: Acute Disease; Animals; Immunologic Factors; Leucine; Mice; Mice, Inbred BALB C; Mice, Nude; Radiation Injuries, Experimental | 1992 |
[Bestatin-induced intravascular hemolysis in a patient with acute myelocytic leukemia].
Topics: Acute Disease; Adjuvants, Immunologic; Adolescent; Anemia, Hemolytic; Female; Hemolysis; Humans; Leucine; Leukemia, Myeloid, Acute | 1990 |